To treat hepatitis C, different treatment methods need to spend different money. At present, the country has basically abandoned the polyethylene glycol interferon therapy, which has a long course of treatment, many side effects and is difficult for patients to accept. At present, the oral treatment drugs that are short in duration, have fewer side effects and are easy for patients to accept include five treatment options: the first is propecia, which is about 69,000 yuan for a course of treatment. The second is Zebeta, which is 39,000 yuan for a course of treatment. The third is Vicenza combined with Echiriza, which is$45,000 for a course of treatment. The fourth one is Brizal combined with Speed, which is about 53,000 yuan for a course of treatment. The fifth is Sovaldi combined with Balize, which is 78,000 yuan for a course of treatment.